Skip to main content

Table 2 Standardized dataset for the cost-effectiveness models in rotavirus vaccination: demography and incidence (Sources: [4, 5, 7, 14, 15, 20, 26, 27])

From: Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world

  Afr Sear Amr Eur Notes
Total # of life births 1,496,200 3,427,800 140,110 190,000  
Life expectancy at birth in years 54 66 73 80 average men & women
Population 34,255,722 141,822,276 5,486,685 16,500,000  
% of population < 5 years 16.8% 16.8% 16.8% 6.1%  
% urban 42% 23% 62% 100%  
Infant mortality (< 1 year of age) 64 45 21 4 per 1000 life births
Mortality < 5 years 104 57 26 0.5 per 1000 life births/yr
Population < 5 years 5,736,373 17,399,197 730,913 1,000,000  
Incidence mild rotavirus gastro-enteritis      
   1st year after birth 1.4% 1.4% 1.4% 1.4% in % per month
   2nd year after birth 0.57% 0.57% 0.57% 0.57% in % per month
   3rd & 4th after birth 0.49% 0.49% 0.49% 0.49% in % per month
Incidence of moderate 38.7% 38.7% 38.7% 33.1% in % from mild
Incidence of severe 7.9% 7.9% 7.9% 12.1% in % from moderate
Incidence of death 18.8% 12.5% 6.3% 0.05% in % from severe
Incidence of nosocomial infections 33.3% 33.3% 33.3% 25% % from severe (on top)